Home / Library / Topic Index / HIV Continuum of Care / Step 1: Preventing New Infections / Pre-exposure Prophylaxis

Pre-exposure Prophylaxis

Active Resources: 34

Webinar Recordings

Curricula

Prevention & Testing Guidelines (PEP, PrEP, PWP)

Online Training

Toolkits

Slide Sets

Online and Self-Paced Learning

Pocket Guides

Reports

Fact Sheets

Primary Care Guidelines

Charts, Tables & Posters

Patient Information

Coinfection Guidelines (Hep, TB, STIs)

Videos

Web Links

Articles: 5

  • U=U in PARTNER2 Study of MSM

    August 21, 2018

    • Susa Coffey, MD, AETC National Coordinating Resource Center, UCSF Center for HIV Information

    PARTNER1, whose results were reported last year,(1) was one of the studies that supported current efforts to promote the growing scientific consensus supporting "Treatment as Prevention" (TasP) or Undetectable = Untransmittable (U=U).

    PARTNER1 evaluated HIV...

  • HIV Meds Update: PrEP Uptake by Sex, Race, and Age

    September 27, 2016

    • Susa Coffey, MD, AETC National Coordinating Resource Center, UCSF Center for HIV Information

    At the ASM Microbe meeting in June, researchers from Gilead Sciences presented data on use of TDF/FTC (Truvada) PrEP in the United States according to sex and race. They evaluated national pharmacy databases to identify prescriptions of TDF/FTC given for PrEP between January 2012 and September...

  • PrEP: Bone Density Improves after Stopping TDF/FTC

    May 4, 2016

    • Susa Coffey, MD, AETC National Coordinating Resource Center, UCSF Center for HIV Information

    Tenofovir disoproxil fumarate (TDF) may cause decreases in bone mineral density (BMD) both in HIV-infected patients treated with TDF-containing ARV regimens and in HIV-uninfected persons who use it for PrEP. A substudy of the large iPrEx trial of TDF/FTC PrEP in MSM and transgender...

  • Tissue Levels of TAF: Too Low for PrEP?

    March 17, 2016

    • Susa Coffey, MD, AETC National Coordinating Resource Center, UCSF Center for HIV Information

    A pharmacokinetic study presented at the Conference on Retroviruses and Opportunistic Infections in Boston in February evaluated concentrations of tenofovir (TFV) and TFV-diphosphate (DP) in genital and rectal tissue and in anogenital fluid samples after administration of oral tenofovir...

  • Listening in on the Warmline, PEPline and the Perinatal HIV Hotline: Consultation when Considering PrEP

    April 25, 2012

    Pre-exposure prophylaxis (PrEP), specifically the daily use of oral antiretroviral drugs as an HIV prevention measure, has been an increasingly hot topic in the HIV world since studies emerged in 2010 showing promising transmission prevention results among medication-adherent men who have sex...
Day Title
9/25
Women and PrEP Symposium (Maryland)
Tuesday, September 25, 2018 - 8:30am EDT (Open Event)
MidAtlantic AETC
Event type: Conferences & Events
10/3
The Fundamentals of Prevention Counseling (Virginia)
Wednesday, October 3, 2018 - 9:00am EDT (Open Event)
MidAtlantic AETC
Event type: Conferences & Events
10/15
HIV Medical Management: Clinical and Didactic Experience for Providers (Pennsylvania)
Monday, October 15, 2018 - 8:00am EDT (Open Event)
MidAtlantic AETC
Event type: Conferences & Events
11/15
National Rural Health Day (National)
Thursday, November 15, 2018 (All day) (Open Event)
Event type: Awareness Days
12/3
2018 Biomedical HIV Prevention Summit (The Summit) (California)
Monday, December 3, 2018 (All day) (Open Event)
National Minority AIDS Council
Event type: Conferences & Events
Day Title
9/6
U.S. Conference on AIDS (USCA) (National, Florida)
Thursday, September 6, 2018 (All day) to Sunday, September 9, 2018 (All day) (Open Event)
National Minority AIDS Council
Event type: Conferences & Events
3/4
CROI 2018: Boston (Online, National, Massachusetts)
Sunday, March 4, 2018 (All day) to Wednesday, March 7, 2018 (All day) (Open Event)
International Antiviral Society-USA
Event type: Conferences & Events